FDA: Anonymity Assured In Pending Cosmetic Manufacturing Practices Survey
This article is powered by The Rose Sheet
Executive Summary
The agency clarified in an email to Rose Sheet that an independent contractor would be tasked with conducting a planned survey on current cosmetic manufacturing practices, which remains subject to public comment and OMB approval. Respondents could count on their responses to be anonymous, FDA says.
You may also be interested in...
FDA Targets Spring 2019 For Cosmetics Manufacturing Survey; PCPC Input Taken
From the Personal Care Products Council’s standpoint, FDA’s planned survey of current manufacturing practices in the cosmetics sector isn’t necessary, but the group provided input to contractor RTI to help develop the instrument for optimal utility. Pending OMB approval, FDA aims to launch the survey in spring 2019.
FDA Appears To Be Prepping For Cosmetics Regulatory Changes, Ingredient Review
Proposed regulatory reform legislation in the Senate would require FDA to review the safety of cosmetics ingredients, taking into account evaluations conducted by accredited third parties. In August, FDA requested quotes from the contractor community for developing a cosmetic hazard and risk assessment protocol and optional certification program “to show compliance with the protocol.”
FDA Announces Planned Survey Of Current Cosmetics Manufacturing Practices
The agency expects 70% of invited manufacturers to provide voluntary detail on their written procedures and records maintenance, equipment and raw materials management, product testing programs, processes for handling complaints and corrective action pathways, among other elements, via a 30-minute survey. Comments on the planned initiative will be accepted through August.